93 related articles for article (PubMed ID: 9757875)
1. Serum leptin concentration in women: effect of age, obesity, and estrogen administration.
Castracane VD; Kraemer RR; Franken MA; Kraemer GR; Gimpel T
Fertil Steril; 1998 Sep; 70(3):472-7. PubMed ID: 9757875
[TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen on serum DHEA in younger and older women and the relationship of DHEA to adiposity and gender.
Kraemer RR; Synovitz LB; Gimpel T; Kraemer GR; Johnson LG; Castracane VD
Metabolism; 2001 Apr; 50(4):488-93. PubMed ID: 11288048
[TBL] [Abstract][Full Text] [Related]
3. Effects of short-term hormone replacement on serum leptin levels in postmenopausal women.
Lavoie HB; Taylor AE; Sharpless JL; Anderson EJ; Strauss CC; Hall JE
Clin Endocrinol (Oxf); 1999 Oct; 51(4):415-22. PubMed ID: 10583307
[TBL] [Abstract][Full Text] [Related]
4. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy.
Bednarek-Tupikowska G; Filus A; Kuliczkowska-Płaksej J; Tupikowski K; Bohdanowicz-Pawlak A; Milewicz A
Gynecol Endocrinol; 2006 Apr; 22(4):207-12. PubMed ID: 16723307
[TBL] [Abstract][Full Text] [Related]
5. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
Dedeoğlu EN; Erenus M; Yörük P
Fertil Steril; 2009 Feb; 91(2):425-31. PubMed ID: 18249383
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
Salbach B; Nawroth PP; Kübler W; von Holst Th; Salbach PB
Eur J Med Res; 2000 Feb; 5(2):63-6. PubMed ID: 10720565
[TBL] [Abstract][Full Text] [Related]
8. Leptin levels in menopause: effect of estrogen replacement therapy.
Cento RM; Proto C; Spada RS; Napolitano V; Ciampelli M; Cucinelli F; Lanzone A
Horm Res; 1999; 52(6):269-73. PubMed ID: 10965205
[TBL] [Abstract][Full Text] [Related]
9. Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy.
Haffner SM; Mykkänen L; Stern MP
Am J Epidemiol; 1997 Oct; 146(7):581-5. PubMed ID: 9326436
[TBL] [Abstract][Full Text] [Related]
10. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.
Nader S; Riad-Gabriel MG; Saad MF
J Clin Endocrinol Metab; 1997 Sep; 82(9):3074-7. PubMed ID: 9284746
[TBL] [Abstract][Full Text] [Related]
11. [Kallikrein concentration in mixed saliva after contraceptive administration or postmenopausal hormone replacement].
Meyer P; Werner E; Polzin A
Laryngorhinootologie; 1998 Sep; 77(9):521-4. PubMed ID: 9795931
[TBL] [Abstract][Full Text] [Related]
12. Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy, in older women.
Kohrt WM; Landt M; Birge SJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3980-5. PubMed ID: 8923847
[TBL] [Abstract][Full Text] [Related]
13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin and longevity.
Koistinen HA; Koivisto VA; Karonen SL; Rönnemaa T; Tilvis RS
Aging (Milano); 1998 Dec; 10(6):449-54. PubMed ID: 10078314
[TBL] [Abstract][Full Text] [Related]
15. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
[TBL] [Abstract][Full Text] [Related]
16. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
[TBL] [Abstract][Full Text] [Related]
17. Serum leptin levels in patients with polycystic ovary syndrome.
Telli MH; Yildirim M; Noyan V
Fertil Steril; 2002 May; 77(5):932-5. PubMed ID: 12009346
[TBL] [Abstract][Full Text] [Related]
18. Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use.
O'Brien SN; Anandjiwala J; Price TM
Obstet Gynecol; 1997 Aug; 90(2):244-8. PubMed ID: 9241302
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
20. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
Chu MC; Cosper P; Nakhuda GS; Lobo RA
Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
